Literature DB >> 22475210

Time-course of antibody responses against Coxiella burnetii following acute Q fever.

P F M Teunis1, B Schimmer, D W Notermans, A C A P Leenders, P C Wever, M E E Kretzschmar, P M Schneeberger.   

Abstract

Large outbreaks of Q fever in The Netherlands have provided a unique opportunity for studying longitudinal serum antibody responses in patients. Results are presented of a cohort of 344 patients with acute symptoms of Q fever with three or more serum samples per patient. In all these serum samples IgM and IgG against phase 1 and 2 Coxiella burnetii were measured by an immunofluorescence assay. A mathematical model of the dynamic interaction of serum antibodies and pathogens was used in a mixed model framework to quantitatively analyse responses to C. burnetii infection. Responses show strong heterogeneity, with individual serum antibody responses widely different in magnitude and shape. Features of the response, peak titre and decay rate, are used to characterize the diversity of the observed responses. Binary mixture analysis of IgG peak levels (phases 1 and 2) reveals a class of patients with high IgG peak titres that decay slowly and may represent potential chronic cases. When combining the results of mixture analysis into an odds score, it is concluded that not only high IgG phase 1 may be predictive for chronic Q fever, but also that high IgG phase 2 may aid in detecting such putative chronic cases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475210      PMCID: PMC9152070          DOI: 10.1017/S0950268812000404

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  21 in total

1.  Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis.

Authors:  P F M Teunis; O G van der Heijden; H E de Melker; J F P Schellekens; F G A Versteegh; M E E Kretzschmar
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

2.  Serologic assessment of the risk of developing chronic Q fever in cohorts of acutely infected individuals.

Authors:  Min-Nan Hung; Li-Jen Lin; Min-Yi Hou; Po-Shan Lin; Yung-Chun Wang; Pei-Yun Shu; Chien-Chou Lin; Hsiu-Ying Lu; Yung-Ching Liu
Journal:  J Infect       Date:  2010-10-27       Impact factor: 6.072

3.  Sustained intensive transmission of Q fever in the south of the Netherlands, 2009.

Authors:  B Schimmer; F Dijkstra; P Vellema; P M Schneeberger; V Hackert; R ter Schegget; C Wijkmans; Y van Duynhoven; W van der Hoek
Journal:  Euro Surveill       Date:  2009-05-14

4.  Chronic Q fever: relevance of serology.

Authors:  Simon Sunder; Guillaume Gras; Frédéric Bastides; Claire De Gialluly; Patrick Choutet; Louis Bernard
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

5.  Follow-up of 686 patients with acute Q fever and detection of chronic infection.

Authors:  Wim van der Hoek; Bart Versteeg; Jamie C E Meekelenkamp; Nicole H M Renders; Alexander C A P Leenders; Ineke Weers-Pothoff; Mirjam H A Hermans; Hans L Zaaijer; Peter C Wever; Peter M Schneeberger
Journal:  Clin Infect Dis       Date:  2011-06-15       Impact factor: 9.079

6.  Biomarker dynamics: estimating infection rates from serological data.

Authors:  P F M Teunis; J C H van Eijkeren; C W Ang; Y T H P van Duynhoven; J B Simonsen; M A Strid; W van Pelt
Journal:  Stat Med       Date:  2012-03-15       Impact factor: 2.373

7.  From acute Q fever to endocarditis: serological follow-up strategy.

Authors:  Cécile Landais; Florence Fenollar; Franck Thuny; Didier Raoult
Journal:  Clin Infect Dis       Date:  2007-04-04       Impact factor: 9.079

8.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

9.  One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings.

Authors:  G J M Limonard; M H Nabuurs-Franssen; G Weers-Pothoff; C Wijkmans; R Besselink; A M Horrevorts; P M Schneeberger; C A R Groot
Journal:  Infection       Date:  2010-09-21       Impact factor: 3.553

10.  The health status of Q-fever patients after long-term follow-up.

Authors:  Gabriëlla Morroy; Jeannette B Peters; Malou van Nieuwenhof; Hans H J Bor; Jeannine L A Hautvast; Wim van der Hoek; Clementine J Wijkmans; Jan H Vercoulen
Journal:  BMC Infect Dis       Date:  2011-04-18       Impact factor: 3.090

View more
  18 in total

1.  Survey of laboratory animal technicians in the United States for Coxiella burnetii antibodies and exploration of risk factors for exposure.

Authors:  Ellen A Spotts Whitney; Robert F Massung; Gilbert J Kersh; Kelly A Fitzpatrick; Deborah M Mook; Douglas K Taylor; Michael J Huerkamp; Jessica C Vakili; Patrick J Sullivan; Ruth L Berkelman
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-11       Impact factor: 1.232

2.  Long-Term immune responses to Coxiella burnetii after vaccination.

Authors:  Gilbert J Kersh; Kelly A Fitzpatrick; Joshua S Self; Brad J Biggerstaff; Robert F Massung
Journal:  Clin Vaccine Immunol       Date:  2012-11-28

3.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

Review 4.  Community-acquired pneumonia related to intracellular pathogens.

Authors:  Catia Cillóniz; Antoni Torres; Michael Niederman; Menno van der Eerden; James Chalmers; Tobias Welte; Francesco Blasi
Journal:  Intensive Care Med       Date:  2016-06-08       Impact factor: 17.440

5.  Serological follow-up in patients with aorto-iliac disease and evidence of Q fever infection.

Authors:  J C J P Hagenaars; N H M Renders; A S van Petersen; S O A Shamelian; M G L de Jager-Leclercq; F L Moll; P C Wever; O H J Koning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-12       Impact factor: 3.267

Review 6.  Antimicrobial therapies for Q fever.

Authors:  Gilbert J Kersh
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

7.  Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii.

Authors:  Susan Raju Paul; Anja Scholzen; Ghazel Mukhtar; Stephanie Wilkinson; Peter Hobson; Richard K Dzeng; Jennifer Evans; Jennifer Robson; Rowland Cobbold; Stephen Graves; Mark C Poznansky; Anja Garritsen; Ann E Sluder
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

8.  Bayesian Validation of the Indirect Immunofluorescence Assay and Its Superiority to the Enzyme-Linked Immunosorbent Assay and the Complement Fixation Test for Detecting Antibodies against Coxiella burnetii in Goat Serum.

Authors:  Michael Muleme; John Stenos; Gemma Vincent; Angus Campbell; Stephen Graves; Simone Warner; Joanne M Devlin; Chelsea Nguyen; Mark A Stevenson; Colin R Wilks; Simon M Firestone
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

9.  Persistent high IgG phase I antibody levels against Coxiella burnetii among veterinarians compared to patients previously diagnosed with acute Q fever after three years of follow-up.

Authors:  Cornelia C H Wielders; Anneroos W Boerman; Barbara Schimmer; René van den Brom; Daan W Notermans; Wim van der Hoek; Peter M Schneeberger
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

10.  Persistent high antibody titres against Coxiella burnetii after acute Q fever not explained by continued exposure to the source of infection: a case-control study.

Authors:  Rana Jajou; Cornelia Christina Henrica Wielders; Monique Leclercq; Jeroen van Leuken; Shahan Shamelian; Nicole Renders; Wim van der Hoek; Peter Schneeberger
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.